Allen L, MacKichan J and Ritschel WA (1982) Manual of symbols, equations & definitions in pharmacokinetics. J Clin Pharmacol 22:1S-23S.
Amidon GL, Sinko PJ and Fleisher D (1988) Estimating human oral fraction dose absorbed: a correlation using rat intestinal membrane permeability for passive and carrier-mediated compounds. Pharm Res 5:651-654.
Amidon GL, Lennernas H, Shah VP and Crison JR (1995) A theoretical basis for a bio-pharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res 12:413-420.
Anderle P, Huang Y and Sadee W (2004) Intestinal membrane transport of drugs and nutrients: genomics of membrane transporters using expression microarrays. Eur J Pharm Sci 21:17-24.
Anderson JR and Pitman IH (1980) Solubility and dissolution rate studies of ergotamine tartrate. J Pharm Sci 69:832-835.
Atkinson AJ Jr (2001) Drug absorption and bioavailability. Princ Clin Pharmacol 31-41.
Badawy SIF, Gray DB, Zhao F, Sun D, Schuster AE and Hussain MA (2006) Formulation of solid dosage forms to overcome gastric pH interaction of the factor Xa inhibitor, BMS-561389. Pharm Res 23:989-996.
Burton PS, Goodwin JT, Vidmar TJ and Amore BM (2002) Predicting drug absorption: how nature made it a difficult problem. J Pharmacol Exp Ther 303:889-895.
Cainelli SR, Chui A, McClure JD Jr and Hunter FR (1974) Facilitated diffusion in erythrocytes of mammals. Comp Biochem Physiol A 48:815-825.
Cao X, Yu LX, Barbaciru C, Landowski CP, Shin HC, Gibbs S, Miller HA, Amidon GL and Sun D (2005) Permeability dominates in vivo intestinal absorption of P-gp substrate with high solubility and high permeability. Mol Pharm 2:329-340.
Cao X, Gibbs ST, Fang L, Miller HA, Landowski CP, Shin HC, Lennernas H, Zhong Y, Amidon GL, Yu LX and Sun D (2006) Why is it challenging to predict intestinal drug absorption and oral bioavailability in human using rat model. Pharm Res 23:1675-1686.
Chidambaram N and Burgess DJ (2000) Mathematical modeling of surface-active and non-surface-active drug transport in emulsion systems. AAPS Pharm Sci 2:E31.
Chiou WL (2001) The rate and extent of oral bioavailability versus the rate and extent of oral absorption: clarification and recommendation of terminology. J Pharmacokinet Pharmacodyn 28:3-6.
Chiou WL and Barve A (1998) Linear correlation of the fraction of oral dose absorbed of 64 drugs between humans and rats. Pharm Res 15:1792-1795.
Chiou WL and Buehler PW (2002) Comparison of oral absorption and bioavailability of drugs between monkey and human. Pharm Res 19:868-874.
Chong S, Dando SA, Soucek KM and Morrison RA (1996) In vitro permeability through caco-2 cells is not quantitatively predictive of in vivo absorption for peptide-like drugs absorbed via the dipeptide transporter system. Pharm Res 13:120-123.
Curatolo W (1987) The lipoidal permeability barriers of the skin and alimentary tract. Pharm Res 4:271-277.
Daugherty AL and Mrsny RJ (1999) Transcellular uptake mechanisms of the intestinal epithelial barrier Part one. Pharm Sci Technol Today 4:144-151.
Dressman JB, Amidon GL, Reppas C and Shah VP (1998) Dissolution testing as aprognos-tic tool for oral drug absorption: immediate release dosage forms. Pharm Res 15:11-22.
Fagerholm U, Johansson M and Lennernas H (1996) Comparison between permeability coefficients in rat and human jejunum. Pharm Res 13:1336-1342.
Feher JJ (1983) Facilitated calcium diffusion by intestinal calcium-binding protein. Am J Physiol 244:C303-307.
Fleisher D, Lippert CL, Sheth N, Reppas C and Wlodyga J (1990) Nutrient effects on intestinal drug absorption. J Control Release 11:41-49.
Frenning G and Stromme M (2003) Drug release modeled by dissolution, diffusion, and immobilization. Int J Pharm 250:137-145.
Hansen JE, Weisbart RH and Nishimura RN (2005) Antibody mediated transduction of therapeutic proteins into living cells. Scientific World Journal 5:782-788.
Higuchi WI and Ho NFH (1988) Membrane transfer of drugs. Int J Pharm 2:10-15.
Jinno J, Kamada N, Miyake M, Yamada K, Mukai T, Odomi M, Toguchi H, Liversidge GG, Higaki K and Kimura T (2006) Effect of particle size reduction on dissolution and oral absorption of a poorly water-soluble drug, cilostazol, in beagle dogs. J Control Release 111:56-64.
Kwan KC (1997) Oral bioavailability and first-pass effects. Drug Metab Dispos 25:1329-1336.
Lennernas H (1998) Human intestinal permeability. J Pharm Sci 87:403-410.
Lennernas H, Nylander S and Ungell AL (1997) Jejunal permeability: a comparison between the Using chamber technique and the single-pass perfusion in humans. Pharm Res 14:667-671.
Liang XJ, Mukherjee S, Shen DW, Maxfield FR and Gottesman MM (2006) Endo-cytic recycling compartments altered in cisplatin-resistant cancer cells. Cancer Res 66: 2346-2353.
Narawane L and Lee VHL (1994) Absorption barriers. Drug Target Deliv 3:1-66.
Oh DM, Curl RL and Amidon GL (1993) Estimating the fraction dose absorbed from suspensions of poorly soluble compounds in humans: a mathematical model. Pharm Res 10:264-270.
Oh DM, Han HK and Amidon GL (1999) Drug transport and targeting. Intestinal transport. Pharm Biotechnol 12:59-88.
Pade V and Stavchansky S (1998) Link between drug absorption solubility and permeability measurements in Caco-2 cells. J Pharm Sci 87:1604-1607.
Rouge N, Buri P and Doelker E (1996) Drug absorption sites in the gastrointestinal tract and dosage forms for site-specific delivery. Int J Pharm 136:117-139.
Schreiner T, Schaefer UF and Loth H (2005) Immediate drug release from solid oral dosage forms. J Pharm Sci 94:120-133.
Shin H-C, Landowski CP, Sun D, Vig BS, Kim I, Mittal S, Lane M, Rosania G, Drach JC and Amidon GL (2003) Functional expression and characterization of a sodium-dependent nucleoside transporter hCNT2 cloned from human duodenum. Biochem Bio-phys Res Commun 307:696-703.
Sun D, Lennernas H, Welage LS, Barnett JL, Landowski CP, Foster D, Fleisher D, Lee KD and Amidon GL (2002) Comparison of human duodenum and Caco-2 gene expression profiles for 12,000 gene sequences tags and correlation with permeability of 26 drugs. Pharm Res 19:1400-1416.
Sun D, Yu LX, Hussain MA, Wall DA, Smith RL and Amidon GL (2004) In vitro testing of drug absorption for drug 'developability' assessment: forming an interface between in vitro preclinical data and clinical outcome. Curr Opin Drug Discov Devel 7:75-85.
Toutain PL and Bousquet-Melou A (2004) Bioavailability and its assessment. J Vet Pharmacol Ther 27:455-466.
Trischitta F, Denaro MG, Faggio C and Lionetto MG (2001) Ca++ regulation of paracel-lular permeability in the middle intestine of the eel, Anguilla anguilla. J Comp Physiol [B] 171:85-90.
Ungell AL, Nylander S, Bergstrand S, Sjoeberg A and Lennernaes H (1998) Membrane transport of drugs in different regions of the intestinal tract of the Rat. J Pharm Sci 87:360-366.
Watanabe E, Takahashi M and Hayashi M (2004) A possibility to predict the absorbability of poorly water-soluble drugs in humans based on rat intestinal permeability assessed by an in vitro chamber method. Eur J Pharm Biopharm 58:659-665.
Yamashita S, Furubayashi T, Kataoka M, Sakane T, Sezaki H and Tokuda H (2000) Optimized conditions for prediction of intestinal drug permeability using Caco-2 cells. Eur J Pharm Sci 10:195-204.
Yee S (1997) In vitro permeability across Caco-2 cells (colonic) can predict in vivo (small intestinal) absorption in man-fact or myth. Pharm Res 14:763-766.
Yoon KA and Burgess DJ (1998) Mathematical modelling of drug transport in emulsion systems. J Pharm Pharmacol 50:601-610.
Yu LX and Amidon GL (1999) A compartmental absorption and transit model for estimating oral drug absorption. Int J Pharm 186:119-125.
Yu LX, Lipka E, Crison JR and Amidon GL (1996) Transport approaches to the biophar-maceutical design of oral drug delivery systems: prediction of intestinal absorption. Adv Drug Deliv Rev 19:359-376.
Zhao YH, Abraham MH, Le J, Hersey A, Luscombe CN, Beck G, Sherborne B and Cooper I (2003) Evaluation of rat intestinal absorption data and correlation with human intestinal absorption. Eur J Med Chem 38:233-243.
Zhou R, Moench P, Heran C, Lu X, Mathias N, Faria Teresa N, Wall Doris A, Hussain Munir A, Smith RL and Sun D (2005) pH-dependent dissolution in vitro and absorption in vivo of weakly basic drugs: development of a canine model. Pharm Res 22:188-192.
Was this article helpful?